What is he best known for?
The fields of study he is best known for:
Rana P. Singh mainly focuses on Silibinin, Cancer research, Internal medicine, Apoptosis and Endocrinology.
His research integrates issues of Cancer, Protein kinase B, Kinase and In vivo in his study of Silibinin.
He interconnects Tumor necrosis factor alpha, Immunology and Cyclin-dependent kinase 1, Cell cycle, Cyclin-dependent kinase 2 in the investigation of issues within Cancer research.
His biological study spans a wide range of topics, including Cancer cell, Tumor suppressor gene and Cell biology.
His study looks at the intersection of Apoptosis and topics like Cell culture with Blood plasma.
He has researched Endocrinology in several fields, including Proliferation index and Cell growth.
His most cited work include:
- Silibinin Strongly Synergizes Human Prostate Carcinoma DU145 Cells to Doxorubicin-induced Growth Inhibition, G2-M Arrest, and Apoptosis (260 citations)
- Anticancer potential of silymarin: from bench to bed side. (230 citations)
- Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. (189 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Apoptosis, Silibinin, Cancer and Cell growth are his primary areas of study.
His work deals with themes such as Cancer cell, Cell cycle, Internal medicine and Endocrinology, which intersect with Cancer research.
Rana P. Singh interconnects Carcinogenesis and Colorectal cancer in the investigation of issues within Apoptosis.
His Silibinin study incorporates themes from Protein kinase B, Prostate cancer, Kinase and In vivo.
His study in Cancer is interdisciplinary in nature, drawing from both Autophagy, Lung cancer, Disease and Immunology.
His study focuses on the intersection of Cell growth and fields such as Cyclin D1 with connections in the field of Cyclin-dependent kinase and Cyclin-dependent kinase 2.
He most often published in these fields:
- Cancer research (63.87%)
- Apoptosis (45.80%)
- Silibinin (42.02%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (63.87%)
- Cancer (31.93%)
- Apoptosis (45.80%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Cancer, Apoptosis, Cell growth and Cancer cell.
The study incorporates disciplines such as Cell cycle checkpoint, Fisetin, Downregulation and upregulation, Cytotoxicity and Programmed cell death in addition to Cancer research.
His work on Cell cycle and Cancer stem cell as part of general Cancer research is frequently linked to DU145, thereby connecting diverse disciplines of science.
His Apoptosis research incorporates themes from Molecular biology and Mitochondrion.
The concepts of his Cell growth study are interwoven with issues in Cyclin D1, Protein kinase B and Silibinin.
His work carried out in the field of Cancer cell brings together such families of science as Cell culture, Metastasis, Mitochondrial ROS and Cell biology.
Between 2016 and 2021, his most popular works were:
- Hazardous effects of chemical pesticides on human health-Cancer and other associated disorders. (127 citations)
- Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells. (42 citations)
- Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells. (42 citations)
In his most recent research, the most cited papers focused on:
Rana P. Singh mainly investigates Cancer research, Apoptosis, Cancer cell, Cell growth and Cancer.
His Cancer research research includes elements of Protein kinase B, Fisetin, EZH2, Cytotoxicity and Cyclin D1.
The various areas that Rana P. Singh examines in his Apoptosis study include Molecular biology, Reactive oxygen species and Mitochondrion.
His work in Cancer cell addresses subjects such as Mitochondrial ROS, which are connected to disciplines such as Mitochondrial respiratory chain, Mitochondrial respiratory chain complex I, Lupeol, Cell cycle checkpoint and HeLa.
His research integrates issues of Natural killer T cell and Annexin in his study of Cell growth.
His Cancer research is multidisciplinary, incorporating perspectives in Immunology and Antigen presentation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
